StreetAlpha.app
Home › Stocks › IRMD

Iradimed Corp (IRMD)

$83.45
▼ −1.64%
LAST CLOSE · NOV 17

IRADIMED makes MRI compatible IV infusion pumps and patient vital signs monitors for hospitals and acute care facilities. It last closed at $83.45 on Nov 17, down 1.64% on the day. IRMD reports earnings on Tue, Feb 9, 2027.

AI Auto Pilots
Is IRMD in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$89.3M
+11.0% vs a year ago
Net income
$24.0M
+13.2% vs a year ago
EPS (diluted)
$1.87
+13.3% vs a year ago
Free cash flow
$26.1M
29.3% margin
Valuation
Market cap
$1.1B
12.8M shares
P/E
44.6
Price over 12 month EPS
Price to sales
11.9
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$63.3M
At Sep 30
Shareholder equity
$106.5M
Shares outstanding
12.8M
At Oct 30
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $41.8M$41.8MFY2021FY2022: $53.3M$53.3MFY2022FY2023: $65.6M$65.6MFY2023FY2024: $73.2M$73.2MFY2024FY2025: $83.8M$83.8MFY2025

From IRMD's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 30). Last 12 months adds up the four latest quarters.

Next report
Feb 9
2027 · Time not announced
Consensus EPS forecast
$0.55
$25.4M revenue est.
Year-ago EPS
$0.54
Same quarter last year
Options-implied move
—
Posted about a week before
Analyst consensus
—
No ratings in 90 days
Loading…

Whale Options Flow

90D

No whale options trades in IRMD in the last 90 days.

Loading…

See today’s whale options flow across the market →

IRMD Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●102 buying vs 97 selling
  • ▼Held by funds -1.1 pts
  • ●Funds holding +1
  • ▲Superinvestors: 3 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding214213+0.5%
In funds' top 10220.0%
Held by funds61.5%62.6%−1.1 pts
New / increased28 / 7417 / 97−10.5%
Reduced / sold out72 / 2561 / 29+7.8%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See IRMD institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether IRMD is in one of them and how their past IRMD trades turned out.

IRMD in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered IRMD in an article yet. Here's the latest on the wider market.

About Iradimed

IRADIMED designs, makes and sells medical devices that are safe to use during magnetic resonance imaging (MRI) scans. Its main products are MRI compatible IV infusion pumps, which deliver anesthesia and other fluids to patients during scans, and a vital signs monitoring system that moves with patients between critical care units and the MRI room. The company also sells related accessories, disposable IV tubing sets and maintenance services. Based in Orlando, Florida, it sells mainly to hospitals and acute care facilities in the United States and abroad.

Headquarters
Orlando, FL